News
SRTS
7.29
+5.96%
0.41
Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates
NASDAQ · 7h ago
Sensus Healthcare Q3 EPS $0.07 Up From $(0.09) YoY, Sales $8.84M Up From $3.90M YoY
Benzinga · 10h ago
SENSUS HEALTHCARE Q3 BASIC EPS USD 0.07
Reuters · 10h ago
SENSUS HEALTHCARE REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS WITH REVENUES MORE THAN DOUBLING VERSUS 2023 THIRD QUARTER
Reuters · 10h ago
*Sensus Healthcare 3Q Rev $8.84M >SRTS
Dow Jones · 10h ago
*Sensus Healthcare 3Q EPS 7c >SRTS
Dow Jones · 10h ago
Press Release: Sensus Healthcare Reports Third -3-
Dow Jones · 10h ago
Press Release: Sensus Healthcare Reports Third -2-
Dow Jones · 10h ago
Earnings Scheduled For November 14, 2024
Benzinga · 19h ago
Sensus Healthcare Inc <SRTS.OQ> expected to post a loss of 1 cent a share - Earnings Preview
Reuters · 2d ago
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 2d ago
Weekly Report: what happened at SRTS last week (1104-1108)?
Weekly Report · 3d ago
Astrana Health, Inc. (ASTH) Meets Q3 Earnings Estimates
NASDAQ · 11/07 23:30
Weekly Report: what happened at SRTS last week (1028-1101)?
Weekly Report · 11/04 12:02
Idexx Laboratories (IDXX) Q3 Earnings Surpass Estimates
NASDAQ · 10/31 11:40
Weekly Report: what happened at SRTS last week (1021-1025)?
Weekly Report · 10/28 11:52
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know
NASDAQ · 10/24 22:15
Weekly Report: what happened at SRTS last week (1014-1018)?
Weekly Report · 10/21 11:47
Weekly Report: what happened at SRTS last week (1007-1011)?
Weekly Report · 10/14 12:24
Weekly Report: what happened at SRTS last week (0930-1004)?
Weekly Report · 10/07 12:10
More
Webull provides a variety of real-time SRTS stock news. You can receive the latest news about Sensus Healthcare Inc through multiple platforms. This information may help you make smarter investment decisions.
About SRTS
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.